Oracle Stock Is Down 58% From Its Peak -- but Revenue Is Still Growing by Double Digits. Time to Buy?

Oracle reported fiscal 2026 revenue up 17% to ~$67.4B and net income up 37% to ~$17B, alongside strong cloud growth (Q4 cloud revenue +47%, OCI +93% to $5.8B). The stock is down 58% to ~$144 from a ~$345.72 record high as concerns center on a debt-funded AI data-center build-out with capex of ~$55.7B and ~$43B of new debt driving deeply negative free cash flow. Backlog surged to $638B (+363% YoY), but the concentration in a few giant AI deals and the risk that spending payoffs lag keeps sentiment cautious despite the valuation at ~25x trailing earnings and ~17x forward.

Analysis

Oracle is increasingly trading like a levered infrastructure financier, not a software compounder. In the next 1-3 months, the main driver is no longer top-line momentum but whether the market believes the build-out can be funded without another round of equity-like dilution through debt spread widening; that makes ORCL unusually sensitive to rates, credit conditions, and any hint that AI customers are slowing prepayments.

The relative winner is NVDA and the broader AI supply chain only if Oracle keeps ordering accelerators at scale; if more customers supply chips themselves, the direct pass-through to NVDA is weaker than the headline backlog suggests. The bigger second-order loser may be Oracle’s own multiple: once investors decide depreciation, power, and financing costs dominate the economics, the stock should rerate closer to an infrastructure/utility valuation than a premium software name. That compression risk matters over 6-18 months, even if near-term revenue stays strong.

Contrarianly, the market may be overpricing the near-term cash burn because backlog quality is not uniform; prepayments and customer-supplied hardware reduce working-capital strain versus a pure self-funded capex story. But the thesis is falsified if free cash flow turns positive before year-end, net debt growth stabilizes, and management shows that incremental capacity is translating into recurring margin expansion rather than just revenue recognition. Until then, the risk/reward favors relative-value expressions over outright bottom-fishing.

Key Decisions for Investors

• Long NVDA / short ORCL as a 6-12 month relative-value pair: thesis is that AI infrastructure demand accrues more cleanly to the chip supplier while ORCL absorbs financing, depreciation, and execution risk. Fade strength in ORCL rather than chasing weakness; cover if ORCL demonstrates positive free cash flow inflection or if NVDA guidance weakens.
• Avoid outright shorting ORCL at current levels unless credit widens further: the stock is already discounting a lot of execution risk, so the cleaner expression is via rallies into resistance or through options, not an aggressive cash short.
• Use ORCL put spreads for event risk over the next 1-2 earnings cycles if the stock rebounds: structure should target downside tied to another capex/debt update, with loss limited if management proves backlog conversion is improving.
• Set an alert on ORCL financing costs and free cash flow, not revenue: if debt issuance accelerates or FCF remains deeply negative into the next quarter, the multiple should compress further; if FCF improves meaningfully, the bear case weakens fast.